English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

ResumenEl término nanotecnología hace referencia a una serie de disciplinas que estudian y manipulan la materia a nivel de la nanoescala. Una de las áreas más importantes de la nanotecnología es la nanomedicina, la cual está enfocada en gran medida en el diseño de nanosistemas de liberación de fármacos que prometen revolucionar las terapias convencionales, especialmente aquellas dirigidas al tratamiento del cáncer. En este trabajo se presentan los aspectos fundamentales de la nanomedicina y el desarrollo de nanoacarreadores de fármacos anticancerígenos, así como los retos y las perspectivas a considerar para que las nanoterapias se conviertan en una realidad.AbstractThe term nanotechnology refers to a number of disciplines intended to study materials and structures at the nanoscale. One of the most important areas of nanotechnology is nanomedicine, which is focused in great extent on the design and development of drug delivery systems. These drug delivery platforms can display very sophisticated properties and unique features, and are considered as the revolution of the conventional chemotherapies, specifically those to treat cancer. In this work we review the concept of nanomedicine and its application on the design of nanocarriers of antineoplastic drugs and highlight some aspects that have to be addressed to translate the drug delivery platforms in to devices with possibilities to reach clinical trials

La nanomedicina y los sistemas de liberación de fármacos: ¿la (r)evolución de la terapia contra el cáncer?